Sanofi Pasteur: Partnerships in emerging markets

Vaccine Market:  Dr Allan Jarvis, Corporate Development Advisor at sanofi pasteur delivered today an interesting presentation at the World Vaccine Congress in Washington about partnerships in the emerging markets. Of the 16 products Sanofi Pasteur currently has in clinical development, everything currently in Phase I has come out of partnerships, as well as several in Phase II, Phase  III and …

#wvcusa – Daria Donati from GE Healthcare Life Sciences: #Vaccines: from self-sufficiency to market reach

  Dr Daria Donati presented today at the World Vaccine Congress in Washington about the vaccine market landscape and the role of emerging economies. There is a strong and growing global market in biologicals – demand doubled from 2006-2011.   New manufacturing approaches are needed that are tailored to the needs of emerging countries.  A key way to bring down costs …

Axel van Trotsenburg @WorldBank discussed about Advanced Market Commitment at #wvcusa

  Advanced Market Commitment: Today at World Vaccine Congress Washington, Axel van Trotsenburg from the World Bank delivered a presentation about Adavanced Market Commitmen. See below the main highlights of his presentation: We are faced with major health challenges that millions each day are dying from.  This is a challenge for the international community to get together and tackle these …

#wvcusa Brazil: insight into #vaccine market trends by Dr. Carlos Gadelha, Ministry of Health, Brazil

Vaccine Market: Dr. Carlos Gadelha – Ministry of Health, Brazil delivered today an interesting presentation at the World Vaccine Congress in Washington about the vaccine market trends in Brazil Dr. Gadelha began his discussion on vaccine market trends in Brazil by saying that political and social transformations are just as important as economic and industrial dynamics. Since 2003, almost 30 …

#wvcusa Daniel Berman -Médecins Sans Frontières Access Campaign Alternate Advanced Market Commitment (AMC) Strategies

Advanced Market Commitment: Daniel Bernan discussed today at the World Vaccine Congress Washington about Advanced Market Commintment strategies and how they were initially designed to stimulate R&D for products that would not have been developed. Daniel Berman posed the question that while AMC was important, could we reach same objectives for less money using other strategies than AMC? MSF vaccinates …

#wvcusa – Kim Bush, the Bill & Melinda Gates Foundation LIVE: catalyzing partnerships and investment in #globalhealth

Global health: Today at World Vaccine Congress Washington, Kim Bush delivered a special keynote address highlighting the importance of combining scientific innovation and great partnerships in order to achieve innovative high impact global health. Mr Kim Bush described the Bill and Melinda Gates Foundation’s commitment to global health, which he emphasized is a truly dynamic area of healthcare. He highlighted …

#wvcusa Dr Mike McQuestion @SabinVaccineInstitute from paternalism to country ownership of national #immunization programs

  Dr Mike McQuestion presented today at the World Vaccine Congress in Washington about ownership of national immunization programs The Sabin Sustainable Immunization Financing Program works to create pathways to country ownership of immunization programs.  The group does advocacy work at high levels through parliamentary briefings, targeted peer exchanges and legislative workshops. Current investment needed to immunize a child in …

#Vaccine production: #Baxter explore avian #cell-lines, but could algae hold the answer…?

In every industry their is always the endless search to find ‘the-next-BIG-thing', and cell culture vaccine production is no different!  Cell lines from African green monkey to carrots, and Chinese hamster ovary to tobacco have been investigated with varying degrees of success. Now, Baxter have published results on a novel avian cell line, while at the University of Arizona, Dr …

GLOBAL SURVEY REPORT OUTLINES 2012 FOCUS

In June 2011, World Vaccine Congress Washington 2012 polled 500 senior vaccine executives to gain their exclusive take on the world of vaccines in 2012 as they see it. Those viewpoints have been collated into a 35 page PDF document for you to download and review. The views made in this document have been used to structure and develop the …